| Reconciliations of Numerators and Denominators Used to Calculate Basic and Diluted Net Income Per Share |
The
reconciliations of the numerators and denominators used to
calculate basic and diluted net income per share are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December
31, |
|
|
|
2013 |
|
|
2012 |
|
|
2011 |
|
|
|
(shares in
thousands) |
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations attributable to DaVita HealthCare Partners
Inc.
|
|
$ |
620,197 |
|
|
$ |
536,236 |
|
|
$ |
496,182 |
|
|
Change in noncontrolling
interest redemption rights in excess of fair value
|
|
|
— |
|
|
|
— |
|
|
|
335 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations for basic earnings per share calculation
|
|
|
620,197 |
|
|
|
536,236 |
|
|
|
496,517 |
|
|
Discontinued operations
attributable to DaVita HealthCare Partners Inc.
|
|
|
13,249 |
|
|
|
(219 |
) |
|
|
(18,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to
DaVita HealthCare Partners Inc. for basic earnings per share
calculation
|
|
$ |
633,446 |
|
|
$ |
536,017 |
|
|
$ |
478,336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding during the period
|
|
|
212,128 |
|
|
|
192,396 |
|
|
|
189,309 |
|
|
Vested stock
units
|
|
|
5 |
|
|
|
6 |
|
|
|
7 |
|
|
Weighted average
contingently returnable shares held in escrow as a result of the
acquisition of HealthCare Partners
|
|
|
(2,194 |
) |
|
|
(366 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares for
basic earnings per share calculation
|
|
|
209,939 |
|
|
|
192,036 |
|
|
|
189,316 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income from
continuing operations per share attributable to DaVita HealthCare
Partners Inc.
|
|
$ |
2.95 |
|
|
$ |
2.79 |
|
|
$ |
2.62 |
|
|
Basic income from
discontinued operations per share attributable to DaVita HealthCare
Partners Inc.
|
|
|
0.07 |
|
|
|
— |
|
|
|
(0.09 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per
share attributable to DaVita HealthCare Partners
Inc.
|
|
$ |
3.02 |
|
|
$ |
2.79 |
|
|
$ |
2.53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations attributable to DaVita HealthCare Partners
Inc.
|
|
$ |
620,197 |
|
|
$ |
536,236 |
|
|
$ |
496,182 |
|
|
Change in noncontrolling
interest redemption rights in excess of fair value
|
|
|
— |
|
|
|
— |
|
|
|
335 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations for diluted earnings per share calculation
|
|
|
620,197 |
|
|
|
536,236 |
|
|
|
496,517 |
|
|
Discontinued operations
attributable to DaVita HealthCare Partners Inc.
|
|
|
13,249 |
|
|
|
(219 |
) |
|
|
(18,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to
DaVita HealthCare Partners Inc. for diluted earnings per share
calculation
|
|
$ |
633,446 |
|
|
$ |
536,017 |
|
|
$ |
478,336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding during the period
|
|
|
212,128 |
|
|
|
192,396 |
|
|
|
189,309 |
|
|
Vested stock
units
|
|
|
5 |
|
|
|
6 |
|
|
|
7 |
|
|
Assumed incremental shares
from stock plans
|
|
|
2,631 |
|
|
|
3,540 |
|
|
|
3,748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares for
diluted earnings per share calculation
|
|
|
214,764 |
|
|
|
195,942 |
|
|
|
193,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income from
continuing operations per share attributable to DaVita HealthCare
Partners Inc.
|
|
$ |
2.89 |
|
|
$ |
2.74 |
|
|
$ |
2.57 |
|
|
Diluted income from
discontinued operations per share attributable to DaVita HealthCare
Partners Inc.
|
|
|
0.06 |
|
|
|
— |
|
|
|
(0.09 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per
share attributable to DaVita HealthCare Partners
Inc.
|
|
$ |
2.95 |
|
|
$ |
2.74 |
|
|
$ |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-dilutive stock-settled
awards excluded from calculation(1)
|
|
|
4,194 |
|
|
|
2,616 |
|
|
|
4,775 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Shares associated with
stock-settled stock appreciation rights and stock options excluded
from the diluted denominator calculation because they are
anti-dilutive under the treasury stock method. |
|